Antiviral activity of biological response modifiers in a murine model of aids. requirement for augmentation of natural killer cell activity and synergy with oral AZT
- 1 November 1996
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 18 (11) , 633-650
- https://doi.org/10.1016/s0192-0561(96)00064-1
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- A Phase II Study of Recombinant Human Interferon-α2a and Zidovudine in Patients with AIDS-Related Kaposi's SarcomaJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Effect of tumor burden and route of administration on the immunotherapeutic properties of polyinosinic-polycytidylic acid stabilized with poly-l-lysine in carboxymethyl cellulose [Poly(I,C)-LC]International Journal of Immunopharmacology, 1992
- Imexon and biological response modifiers in murine models of aidsInternational Journal of Immunopharmacology, 1991
- Interferon-??2a in the Treatment of Acquired Immunodeficiency Syndrome-Related Kaposi??s SarcomaJournal of Immunotherapy, 1991
- The mechanism of action of a synthetic immunomodulator, 3,6-Bis(2-piperidinoethoxy)acridine trihydrochloride (CL 246, 738), in natural killer cell activation in animalsInternational Journal of Immunopharmacology, 1991
- Flow cytometric analysis of γδ T cells and natural killer cells on HIV-1 infectionClinical Immunology and Immunopathology, 1991
- Pathogenesis of the natural killer cell deficiency in AIDSImmunology Today, 1990
- Antiviral Efficacy of Imexon in the Rauscher Murine Retrovirus Aids ModelImmunopharmacology and Immunotoxicology, 1990
- The Role of Natural Killer Cells in Immune SurveillanceNew England Journal of Medicine, 1989
- Severe Herpesvirus Infections in an Adolescent without Natural Killer CellsNew England Journal of Medicine, 1989